JCJean‐François Cantaloube

Jean‐François Cantaloube

*This is an algorithmically generated author record based on publicly available information.

Research Subjects


Jean‐François Cantaloube has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Francois Jordier

    Unité Emergence et coévolution virale, UMR 6578, CNRS—Etablissement Français du Sang Alpes‐Méditerranée, Marseille, France

    1 shared publication
  • Françoise Bouchardeau

    Institut National de Transfusion Sanguine, Paris, France

    1 shared publication
  • Houssam Attoui

    UMR1161 Virologie, INRAE, Ecole Nationale Vétérinaire d’Alfort, ANSES, Université Paris-Est, 94700 Maisons-Alfort, France

    1 shared publication
  • Marie‐Héléne Elghouzzi

    EFS Ile de France, Rungis, France

    1 shared publication
  • Philippe Biagini

    Unité Emergence et coévolution virale, UMR 6578, CNRS—Etablissement Français du Sang Alpes‐Méditerranée, Marseille, France

    1 shared publication
  • Philippe de Micco

    Unité Emergence et coévolution virale, UMR 6578, CNRS—Etablissement Français du Sang Alpes‐Méditerranée, Marseille, France

    1 shared publication

Latest Publications

  • Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors

    by Jean‐François Cantaloube, Pierre Gallian, Syria Laperche, Marie‐Héléne Elghouzzi, Yves Piquet, Françoise Bouchardeau, Francois Jordier, Philippe Biagini, Houssam Attoui, Philippe de Micco

    The subtype distribution of 142 genotype 2 and 97 genotype 4 hepatitis C virus (HCV) isolates from the sera of 1,319 volunteer blood donors in France was determined by gene sequencing and by phylogenetic analysis of the NS5B region and E1 envelope. Findings underlined a wide range of subtypes in both genotypes, that is, 20 in HCV‐2 and 11 in HCV‐4. Eighteen of these 31 subtypes had not been defined previously. Some subtypes, that is, 2a, 2b, 2c, 2i, 2k, 4a, and 4d, showed numerous strains while subtypes in donors from West Africa or Central Africa showed an endemic profile with only a few strains. A Bayesian coalescence approach was used to estimate the demographic history of each HCV subtype. The estimated mean dates of the most recent common ancestors (MRCA) were 1,889 (confidence interval (CI), 1,842–1,930) for HCV‐2a, 1,886 (CI, 1,843–1,921) for HCV‐2b, 1,791 (CI, 1,699–1,848) for HCV‐2c, 1,846 (CI, 1,803–1,878) for HCV‐2i, 1,911 (CI, 1,879–1,937) for HCV‐4a, and 1,957 (CI, 1,943–1,967) for HCV‐4d. The period of spread for subtype 2b, 2c, and 2i was between 1900 and 1960 whereas rapid exponential spread for subtype 2a, 4a, and 4d occurred in the 1960s. The inferred histories of population growth indicated that transmission rates differed according to HCV subtype. These results may help to predict the future burden of HCV in France. J. Med. Virol. 80:1732–1739, 2008.